MedTrace Logo

The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo

NCT03247400 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-09-23

No results posted yet for this study

Summary

The aim of this study is to evaluate the influence of simvastatin and atorvastatin on vitiligous lesions in patients with non-segmental vitiligo.

Conditions

  • Non-segmental Vitiligo

Interventions

DRUG

1% simvastatin-acid sodium salt ointment

1% simvastatin-acid sodium salt ointment applied onto a predefined limb

DRUG

1% atorvastatin calcium salt ointment

1% atorvastatin calcium salt ointment applied onto a predefined limb

Sponsors & Collaborators

  • Nicolaus Copernicus University

    lead OTHER

Principal Investigators

  • Rafal Czajkowski, Prof NCU · Head of Chair and Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Medical College in Bydgoszcz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-12-31
Completion
2019-04-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03247400 on ClinicalTrials.gov